Iron Gate Global Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$909K Sell
988
-75
-7% -$76K 0.1% 42
2025
Q4
$1.14M Sell
1,063
-36
-3% -$34.4K 0.12% 36
2025
Q3
$838K Buy
1,099
+700
+175% +$521K 0.09% 47
2025
Q2
$311K Buy
399
+44
+12% +$34.2K 0.03% 66
2025
Q1
$294K Buy
+355
New +$295K 0.04% 70
2024
Q4
Sell
-252
Closed -$224K 93
2024
Q3
$224K Buy
252
+1
+0.4% +$899 0.03% 81
2024
Q2
$228K Buy
+251
New +$201K 0.04% 89

Other funds holding LLY

Iron Gate Global Advisors's LLY Position: Q1 2026 in Review

Iron Gate Global Advisors reduced its Eli Lilly (LLY) stake by 7.1% in Q1 2026, selling an estimated $76K and leaving 988 shares worth $909K. The position accounts for 0.1% of the portfolio, ranked #42.

Iron Gate Global Advisors first reported a position in LLY in Q2 2024 and has held it in 7 quarters since. The position peaked at $1.14M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Iron Gate Global Advisors held 988 shares of Eli Lilly worth $909K as of Q1 2026.
  • Iron Gate Global Advisors sold 75 Eli Lilly shares in Q1 2026, an estimated $76K.
  • Eli Lilly made up 0.1% of Iron Gate Global Advisors's portfolio in Q1 2026, its #42 holding.
  • Iron Gate Global Advisors first reported a position in Eli Lilly in Q2 2024 and has held it in 7 quarters since.
  • Iron Gate Global Advisors's Eli Lilly position peaked at $1.14M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Iron Gate Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.